SCHEMBL22288724

SCHEMBL22288724

COC(=O)CNC(=O)c1ccc(OCc2ccccc2)c(C(F)(F)F)c1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RXRA P19793 2/20 0.53
RXRB P28702 2/20 0.53
RXRG P48443 2/20 0.53
SMPD1 P17405 2/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
MRGPRX4 Q96LA9 10/20 0.52
BRD4 O60885 2/20 0.48
PPARG P37231 1/20 0.48
PPARD Q03181 1/20 0.48
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22288671 0.89 RXRA (0.51) RXRARXRBRXRGSMPD1HDAC1
SCHEMBL22308853 0.88 BRD4 (0.61) RXRARXRBRXRGSMPD1HDAC1
SCHEMBL28033750 0.85 SMPD1 (0.73) RXRASMPD1HDAC1HDAC8HDAC6
SCHEMBL3901919 0.84 MRGPRX4 (0.69) RXRARXRBRXRGSMPD1HDAC1
SCHEMBL2950475 0.84 RXRA (0.59) RXRARXRBRXRGSMPD1HDAC1
SCHEMBL28034416 0.82 PDE4B (0.58) SMPD1HDAC1HDAC8HDAC6BRD4
SCHEMBL1437991 0.82 RXRA (0.61) RXRARXRBRXRGSMPD1HDAC1
SCHEMBL79709 0.81 RXRA (0.72) RXRARXRBRXRGMRGPRX4MEN1
SCHEMBL5030286 0.81 RXRA (0.55) RXRARXRBRXRGSMPD1HDAC1
SCHEMBL5029139 0.81 PTPRC (0.56) RXRARXRBRXRGSMPD1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020157189-A1 1,2,4-TRIAZIN-6(1H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES BAYER AKTIENGESELLSCHAFT (DE) 2020-08-06 WO disclosed
WO-2020157189-A1 1,2,4-TRIAZIN-6(1H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES BAYER AKTIENGESELLSCHAFT (DE) 2020-08-06 WO disclosed